Following a biochemistry degree at Imperial College London, Dr Nick Burfitt worked in the City for Credit Lyonnaise Rouse before taking up full-time training with the British Olympic Rowing Team.
After this break from work, he went on to study medicine, qualifying from Cambridge University in 1997. Dr Burfitt completed surgical training at St George’s Hospital, then transferred to St Mary’s Hospital for radiology training with an interventional radiology fellowship at Charing Cross Hospital, where he became a consultant in 2008.
Dr Burfitt leads the prostate artery embolization (PAE) for benign prostatic hyperplasia (BPH) service at Imperial. Following training in Lisbon with Dr Pisco, the originator of PAE, in 2015 he started the PAE programme at Imperial College Healthcare and was the site primary operator for the UK-ROPE study which has recently led to NICE approval of PAE. Dr Burfitt is expert in the use of embolization throughout the body: varicocele embolization, uterine fibroid embolization, treatment gastrointestinal or traumatic bleeding.
He is currently developing musculoskeletal embolization (MSKE) for chronic tendon and joint pain at the Trust, having travelled to Japan recently to observe this new technique.
Other areas of expertise include deep venous stenting with intravascular ultrasound, peripheral arterial angioplasty and stenting, complex aortic aneurysm endovascular repair, venous access for oncology/dialysis and endo-urological intervention.